{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:25:01Z","timestamp":1649089501225},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/rlu.0000000000001554","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T11:51:44Z","timestamp":1487073104000},"page":"391-393","source":"Crossref","is-referenced-by-count":0,"title":["223Ra Dichloride Bone-Targeted Therapy in a Case of Metastatic Salivary Duct Carcinoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Matteo","family":"Manfredi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Airoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Buttigliero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Parente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Angusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210204","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1002\/hed.23383","article-title":"Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy","volume":"36","author":"Soper","year":"2014","journal-title":"Head Neck"},{"key":"R2-19-20210204","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1200\/JCO.2010.32.8351","article-title":"Androgen receptor\u2013positive salivary duct carcinoma: a disease entity with promising new treatment options","volume":"29","author":"Jaspers","year":"2011","journal-title":"J Clin Oncol"},{"key":"R3-19-20210204","first-page":"3781","article-title":"Paclitaxel and carboplatin for recurrent salivary gland malignancies","volume":"20","author":"Airoldi","year":"2000","journal-title":"Anticancer Res"},{"key":"R4-19-20210204","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/030089168907500312","article-title":"Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland","volume":"75","author":"Airoldi","year":"1989","journal-title":"Tumori"},{"key":"R5-19-20210204","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4161\/cbt.28410","article-title":"Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy","volume":"15","author":"Locati","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"R6-19-20210204","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(14)70183-4","article-title":"Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial","volume":"15","author":"Sartor","year":"2014","journal-title":"Lancet Oncol"},{"key":"R7-19-20210204","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(14)70474-7","article-title":"Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"R8-19-20210204","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2967\/jnumed.112.112482","article-title":"Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: \u03b1 therapy with 223Ra-dichloride","volume":"55","author":"Pandit-Taskar","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:17:58Z","timestamp":1620973078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201705000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001554","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}